Projecten per jaar
Persoonlijk profiel
Expertise
I obtained my master in Biomedical Sciences from the Vrije Universiteit Brussel (VUB) in 2014. In 2014, I started my PhD under the supervision of Prof. Nick Devoogdt in the In vivo Cellular and Molecular Imaging (ICMI) lab, VUB. During my PhD, I have been focusing on evaluating the potential of radiolabeled single domain antibody fragments for radionuclide-based imaging and targeted radionuclide therapy of Non-Hodgkin lymphoma. I defended my PhD in 2019. As a postdoctoral researcher, my interest is on the investigation of the effects on the immune response after targeted radiation of cancer cells.
Vingerafdruk
Verdiep u in de onderzoeksgebieden waarop Ahmet Krasniqi actief is. Deze onderwerplabels komen uit het werk van deze persoon. Samen vormen ze een unieke vingerafdruk.
- 12 Soortgelijke profielen
Netwerk
Recente externe samenwerking op landenniveau. Duik in de details door op de stippen te klikken.
Projecten
-
IWT710: Gerichte radionuclidentherapie van non-hodgkin lymfoom met anti-CD20 nanobodies
1/01/15 → 31/12/18
Project: Fundamenteel
-
BRGRD36: Joint R&D Project: Invigorating precision medicine by predictive imaging of SDAB-based anti-cancer theranostics
Keyaerts, M., Breckpot, K. & Krasniqi, A.
1/01/70 → 4/10/19
Project: Fundamenteel
Onderzoeksoutput
-
Identification of Nanobodies against the Acute Myeloid Leukemia Marker CD33
Romão, E., Krasniqi, A., Maes, L., Vandenbrande, C., Sterckx, Y. G-J., Stijlemans, B., Vincke, C., Devoogdt, N. & Muyldermans, S., 2 jan 2020, In : International Journal of Molecular Sciences. 21, 1, 310.Onderzoeksoutput: Article
4 Citaten (Scopus) -
Investigating immune activation upon beta targeted radionuclide therapy using anti-CD20 single domain antibody fragments in melanoma
Ertveldt, T., Dekempeneer, Y., De Beck, L., Goyvaerts, C., Lecocq, Q., De Vlaeminck, Y., Awad, R. M., Devoogdt, N., Keyaerts, M., D'Huyvetter, M., Breckpot, K. & Krasniqi, A., 7 feb 2020, blz. page 79. 1 blz.Onderzoeksoutput: Poster
-
Does targeted radionuclide therapy using 177Lutetium induce immune activation upon treatment?
Ertveldt, T., Krasniqi, A., Keyaerts, M., Goyvaerts, C., Lecocq, Q., De Vlaeminck, Y., Awad, R. M., De Beck, L., Dekempeneer, Y., Devoogdt, N., D'Huyvetter, M. & Breckpot, K., 7 jun 2019.Onderzoeksoutput: Poster
-
Immunogenic effect of targeted radionuclide therapy-induced tumor cell death
Ertveldt, T., Krasniqi, A., D'Huyvetter, M., Goyvaerts, C., Lecocq, Q., De Vlaeminck, Y., Awad, R. M., De Beck, L., Devoogdt, N., Keyaerts, M. & Breckpot, K., 25 jun 2019.Onderzoeksoutput: Poster
-
Moleculaire beeldvorming met radioactief gemerkte nanobodies
Krasniqi, A., 9 nov 2019.Onderzoeksoutput: Unpublished abstract
Prijzen
-
Alavi-Mandell Award from Journal of Nuclear Medicine
Ahmet Krasniqi (Recipient), Matthias D'Huyvetter (Recipient), Nick Devoogdt (Recipient) & Marleen Keyaerts (Recipient), 16 apr 2019
Prijs: Prize (including medals and awards)
-
Travel Stipend WMIC 2016 - Best Preclinical Paper
Ahmet Krasniqi (Recipient), sep 2016
Prijs: Prize (including medals and awards)
Activiteiten
-
2020-69
Marleen Keyaerts (Supervisor), Ahmet Krasniqi (Contributor), Cindy Peleman (Contributor), Kevin De Jonghe (Contributor), Yoline Lauwers (Contributor)2020Activiteit: Other
-
2020-78
Nick Devoogdt (Supervisor), Marleen Keyaerts (Supervisor), Ahmet Krasniqi (Contributor)2020 → …Activiteit: Other
-
Targeted radionuclide therapy of Non-Hodgkin lymphoma with theranostic anti-hCD20 Nb
Ahmet Krasniqi (Speaker), Matthias D'Huyvetter (Contributor), Catarina Xavier (Contributor), Kevin Van Der Jeught (Contributor), Serge Muyldermans (Contributor), Tony Lahoutte (Contributor), Jan Tavernier (Contributor), Nick Devoogdt (Contributor)28 mrt 2017Activiteit: Talk or presentation at a conference
-
Targeted radionuclide therapy of Non-Hodgkin lymphoma with 177Lu-radiolabeled anti-hCD20 Nb
Ahmet Krasniqi (Speaker), Matthias D'Huyvetter (Contributor), Catarina Xavier (Contributor), Kevin Van Der Jeught (Contributor), Serge Muyldermans (Contributor), Tony Lahoutte (Contributor), Jan Tavernier (Contributor), Nick Devoogdt (Contributor)16 mei 2017Activiteit: Talk or presentation at a conference
-
Forethought on Using Macrophage Mannose Receptor as Target in Atherosclerosis
Gezim Bala (Contributor), Henri Vincent Baudhuin (Contributor), Kris Gillis (Contributor), Isabel Remory (Contributor), Ahmet Krasniqi (Contributor), Tony Lahoutte (Contributor), Nick Devoogdt (Contributor), Steven Droogmans (Contributor), Bernard Cosyns (Contributor), Sophie Hernot (Speaker)3 feb 2016Activiteit: Talk or presentation at a conference
Scriptie
-
Evaluation of TRNT-mediated immunogenic effects
Auteur: Krasniqi, A., Hugé, H. L. S., D'Huyvetter, M. & Raes, G., 2020Begeleider: Krasniqi, A. (Advisor)
Scriptie/masterproef: Master's Thesis
-
Immunogenic effect of targeted radionuclide therapy-induced tumor cell death
Auteur: Ertveldt, T., Breckpot, K., Keyaerts, M., D'Huyvetter, M. & Krasniqi, A., 15 jun 2019Begeleider: Krasniqi, A. (Promotor)
Scriptie/masterproef: Master's Thesis
-
Increased tumor targeting potential of anti-human CD20 Nanobodies to treat Non-Hodgkin Lymphoma
Auteur: Krasniqi, A., Bialkowska, M., Devoogdt, N. & D'Huyvetter, M., 2016Begeleider: Krasniqi, A. (Advisor)
Scriptie/masterproef: Master's Thesis
-
Preclinical evaluation of targeted radionuclide therapy of Non-Hodgkin Lymphoma using nanobody-based anti-CD20 probes
Auteur: Bialkowska, M., Devoogdt, N., Muyldermans, S. & D'Huyvetter, M., 30 aug 2016Begeleider: Krasniqi, A. (Advisor)
Scriptie/masterproef: Master's Thesis
-
Preclinical evaluation of targeted radionuclide therapy of Non-Hodgkin Lymphoma using nanobody-based anti-CD20 probes
Auteur: Bialkowska, M. & Devoogdt, N., 2016Begeleider: Krasniqi, A. (Promotor)
Scriptie/masterproef: Master's Thesis